Crossmark

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

Crossref DOI link: https://doi.org/10.1007/s40263-018-0539-z

Published Online: 2018-07-18

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leweke, F. Markus https://orcid.org/0000-0002-8163-195X
Mueller, Juliane K.

Lange, Bettina

Fritze, Stefan

Topor, Cristina E.

Koethe, Dagmar

Rohleder, Cathrin
License Information

Text and Data Mining valid from 2018-07-01
More Information

Article History

First Online: 18 July 2018

Compliance with Ethical Standards

:

: F. Markus Leweke is a shareholder of Curantis UG (Ltd) and has received Research Grants from Acerus Pharmaceuticals. Juliane K. Mueller, Bettina Lange, Stefan Fritze, Cristina E. Topor, Dagmar Koethe and Cathrin Rohleder declare that they have no conflicts of interest.

: This work received intramural funding from Central Institute of Mental Health (CIMH) (FML).